Note to Houston-area patients: |
Sorry, not currently accepting new patients due to research/work schedule. Please check back periodically. Email/phone consultations are available only for established patients. |
| Front page |
| Main page |
| Credentials and Overview |
Office Location |
| Appointments and Consultations |
| Clinical Art and Sciences |
| Textbooks and Seminars for Doctors |
| Contents of This Site |
|
|
|
“Bastyr is the leading academic force in natural medicine. I have great respect for the school...” Andrew Weil, MD |
|
|
|
Dr Vasquez has relocated to Fort Worth and is still available by 
HIV, hepatitis, cold, flu, viral infections, herpes, zoster, shingles, viral hepatitis, HIV, hepatitis, cold, flu, viral infections, herpes, zoster, shingles, viral hepatitis
Natural Treatments for Viral Infections in Fort Worth, Texas
We have many safe and effective natural treatments for viral infections, and these treatments have been proven to reduce the severity of infections in patients with a wide range of different viral infections, including:
| Type of infection | Benefits from natural treatments documented in research |
| HIV |
|
| Viral hepatitis and chronic liver disease |
|
| Cold and flu |
|
| Herpes zoster, "shingles" |
|
Natural Medicines include the following general categories:
prescription diets
vitamins
minerals
amino acids
fatty acids
antioxidants
hormones
botanical medicines and herbs
physical medicine
I have helped many patients with viral hepatitis, HIV, herpes and other viral infections to attain better health with the use of treatment plans that focus on treating the underlying biochemistry that promotes and perpetuates the disorder.
Viruses only reproduce and "replicate" in the body because human cells have begun making the virus. We can stop or slow this process with the use of selected nutrients and botanical medicines. The end result is a reduction in the severity of the illness, and significant improvements in the quality of life.
Additionally, we also have many different treatments to "stimulate the immune system" and to thus reduce the severity of the primary infection, as well as reduce the occurrences of secondary infections.
All of the treatments that I use are safe, natural and are backed by clinical experience and/or current biomedical research published in mainstream medical journals. Please call to schedule your appointment so that you or your family member can start on the road to greatly improved health.
J Holist Nurs 2002 Sep;20(3):264-78
Complementary therapy use in persons with HIV/AIDS.
Kirksey KM, Goodroad BK, Kemppainen JK, Holzemer WL, Bunch EH, Corless IB, Eller LS, Nicholas PK, Nokes K, Bain C.
California State University, Fresno, USA.
The purpose of this study was to describe the frequency and correlates of complementary and alternative medicine (CAM) therapies used by people with HIV/AIDS to manage illness and treatment-related symptoms. Data were collected from a convenience sample (N = 422) of people living with HIV disease. Demographic variables (e.g., education, age, and gender) were compared for those who reported using at least one CAM therapy. There were significant differences for gender (chi2 = 4.003, df = 1, p = .045) and for ethnicity (chi2 = 6.042, df = 2, p = .049). Females and African Americans used CAM more frequently. More than one third of the participants used CAM, and there were a total of 246 critical incidents of nontraditional treatment use. It is possible that these nonallopathic interventions may positively affect health-related quality of life in persons with HIV by ameliorating or reducing the side effects associated with the disease and its treatments.
Scand J Gastroenterol 1999 Jan;34(1):29-34
Intestinal absorption and permeability in human immunodeficiency virus-infected patients.
Pernet P, Vittecoq D, Kodjo A, Randrianarisolo MH, Dumitrescu L, Blondon H, Bergmann JF, Giboudeau J, Aussel C.
Biochemistry Dept. A, Hopital Saint-Antoine, Paris, France.
BACKGROUND: Impaired intestinal function could account for diarrhoea and weight loss, which are common features of advanced human immunodeficiency virus (HIV) infection. METHODS: We assessed intestinal permeability to lactulose and mannitol and absorption of D-xylose in 96 HIV-infected patients (group I: asymptomatic subjects (CDC-A); group II: symptomatic subjects (CDC-B or C) without body weight loss and/or diarrhoea; group III: 25 acquired immunodeficiency syndrome (AIDS) patients (CDC-C) with severe body weight loss and/or diarrhoea) and 10 healthy subjects as controls. RESULTS: An incremental decrease in urinary D-xylose recoveries was observed, with all groups statistically different from each other. Impaired intestinal permeability was only found in patients of group III (statistically different from all other groups). CONCLUSIONS: These findings suggest a loss of intestinal functional absorptive surface as HIV disease progresses. This process may be present at the early stage of infection. Impaired intestinal permeability is observed later in AIDS patients when digestive signs are present, particularly diarrhoea.
AIDS 1996 Oct;10(12):1385-91
Intestinal inflammation, ileal structure and function in HIV.
Bjarnason I, Sharpstone DR, Francis N, Marker A, Taylor C, Barrett M, Macpherson A, Baldwin C, Menzies IS, Crane RC, Smith T, Pozniak A, Gazzard BG.
Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London, UK.
OBJECTIVES: This study examines small intestinal absorption-permeability, intestinal inflammation and ileal structure and function in HIV-positive male homosexuals. METHODS: Thirty HIV-seropositive male homosexuals at various stages of disease underwent intestinal absorption permeability and 111indium leukocyte studies (for quantification of intestinal inflammation). Twenty-six men with AIDS had a dual radioisotopic ileal function test (whole body retention of tauro 23-[75Se]-selena 25-homocholic acid and 58cobalt-labelled cyanocobalamine), and 17 underwent ileocolonoscopy with terminal ileal biopsy. RESULTS: Well, HIV-infected, subjects had normal intestinal absorption-permeability, but both functions were impaired upon the development of AIDS. The median faecal excretion of 111indium in well patients (0.66%) did not differ significantly (P > 0.5) from controls (0.46%), but subjects with AIDS who were well or who had diarrhoea had significant (P < 0.005) intestinal inflammation (1.33% and 2.18%, respectively). The median 7-day retention of tauro 23-[75Se]-selena 25-homocholic acid in well patients with AIDS (38.9%) did not differ significantly (P > 0.2) from controls (39.3%), whereas the absorption of 58cobalt-labelled cyanocobalamine was significantly (P < 0.05) lower than controls (32.1% and 59.4%). Patients with AIDS-diarrhoea had significant (P < 0.001) malabsorption of both the bile acid (7.7%) and vitamin B12 (8.9%) which was more severe than in Crohn's ileitis (14.2% and 30.3%, respectively). Morphometric analyses of ileal biopsies were unremarkable in AIDS. CONCLUSIONS: These studies demonstrate a low-grade enteropathy in patients with AIDS, severe ileal malabsorption in patients with AIDS diarrhoea and relatively minor ileal morphologic changes. Malabsorption of bile acids may play a pathogenic role in patients with AIDS and diarrhoea.
